Drug Trial Radar · NCT07819188
SCTB35 and SCTB41 With or Without Chemotherapy in Non-Hodgkin Lymphoma
Last checked: Nov 19, 2026Latest source record: Sep 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
90
Planned (sponsor's estimate)
Start
Sep 30, 2026
Primary completion
Sep 30, 2028
Study completion Sep 30, 2029
Sponsor
- Lead sponsor
- Sinocelltech Ltd.Industry
- Sponsor type
- Industry
- First posted
- Sep 14, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the pharmacokinetics, safety, tolerability and efficacy of SCTB35 and SCTB41 With or Without Chemotherapy in non-Hodgkin's lymphoma patients.
Conditions
- NHL - Non-Hodgkin's Lymphoma
Interventions
SCTB35 injectionDrug
SCTB35 will be subcutaneously administered at a dose as specified
SCTB41Drug
SCTB41 will be IV administered at a dose as specified
Primary outcomes
What the sponsor says the trial is designed to measure.
- Phase 1: dose limited toxicity (DLT)Time frame: Within 28 days of the first administration
- Phase 2: Percentage of Participants Achieving Objective Response Rate (ORR)Time frame: Up to approximately 3 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Tianjing, Tianjing, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.